Results 281 to 290 of about 29,459,690 (400)

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

open access: yesMolecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul   +11 more
wiley   +1 more source

Public Health in the Defense Program. Report of the Committee on Public Health in the Defense Program to the Executive Board, American Public Health Association

open access: green, 1951
Harry S. Mustard   +7 more
openalex   +2 more sources

Analgesic and adjuvant co-prescribing in Australian and Finnish residential care homes. [PDF]

open access: yesAustralas J Ageing
Dowd LA   +9 more
europepmc   +1 more source

Essential diagnostics: mind the gap

open access: yesThe Lancet Global Health, 2021
The Lancet Global Health
doaj  

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

open access: yesMolecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef   +10 more
wiley   +1 more source

Enhancing, and protecting, maternal and neonatal health care

open access: yesThe Lancet Global Health, 2021
The Lancet Global Health
doaj  

Home - About - Disclaimer - Privacy